Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...
Alloy Therapeutics today announced the appointment of Christian Cobaugh, Ph.D., as Chief Executive Officer of Alloy Genetic ...
Unlike traditional GLP-1 therapies, which often cause muscle loss alongside fat reduction, WVE-007 achieved a 9.4% reduction ...
This Research Topic invites high-impact research that advances nanotechnology-enabled antiviral interventions across the pipeline from molecular design to ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
RNAi (RNA interference) is a biological process in which RNA molecules—microRNA (miRNA) and small interfering RNA (siRNA)—inhibit gene expression, typically by binding to messenger RNA (mRNA) and ...
Have you ever wondered why some designs click with people but others fall flat? It isn’t magic, but it might as well be. Enter design elements – the basic units of building that transform a blank ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback